Sage Journals: Discover world-class research

Open access

Review article

First published 2023

Direct GDP-KRAS G12C inhibitors and mechanisms of resistance: the tip of the iceberg

Joshua C. Rosen, Adrian Sacher, Ming-Sound Tsao

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2025

Immunotherapy in advanced,KRAS G12C-mutant non-small-cell lung cancer: current strategies and future directions

Nadia Ghazali, Marina C. Garassino, Natasha B. Leighl [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2025

Potency and Safety of KRAS G12C Inhibitors in Solid Tumors: A Systematic Review

Sara El Zaitouni, Abdelilah Laraqui, Youssra Boustany [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2022

Characterizing the KRAS G12C mutation in metastatic colorectal cancer: a population-based cohort and assessment of expression differences in The Cancer Genome Atlas

Meredith Li, Faeze Keshavarz-Rahaghi, Gale Ladua [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2021-10

Nonclinical Safety Profile of Sotorasib,a KRAS G12C -Specific Covalent Inhibitor for the Treatment of KRAS p.G12C -Mutated Cancer

Katsu Ishida, Jonathan A. Werner, Rhian Davies [...]

International Journal of Toxicology

Retricted access

Research article

First published 2006-05

Case Reports: Follicular Carcinoma Presenting as Autonomous Functioning Thyroid Nodule and Containing an Activating Mutation of the TSH Receptor (T620I) and a Mutation of The Ki-RAS (G12C) Genes

Hugo Niepomniszcze, Horacio Suárez, Fabián Pitoia [...]

Thyroid®

Open access

Research article

First published 2021

Cetuximab–siRNA Conjugate Linked Through Cationized Gelatin Knocks Down KRAS G12C Mutation in NSCLC Sensitizing the Cells Toward Gefitinib

K. Sreedurgalakshmi, R. Srikar, K. Harikrishnan [...]

Technology in Cancer Research & Treatment

Retricted access

Review article

First published 2025-2

KRAS inhibitors in drug resistance and potential for combination therapy

Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale

Tumori Journal

Retricted access

Research article

First published 2022-4

Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma

Ali Gökyer, Ahmet Küçükarda, Osman Köstek [...]

Tumori Journal

Open access

Research article

First published 2024

Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations

Nadia Ghazali, Jamie Feng, Katrina Hueniken [...]

Therapeutic Advances in Medical Oncology

Search results